Table 4: The
scores of the individual DTSQs (A) and DTSQc (B) at post-trial.
(A)
|
Basal insulin
group (n = 17) |
Premixed
insulin group (n = 16) |
P value |
1. Current treatment |
4.31 ± 1.45 |
3.81 ± 0.98 |
0.2618 |
2. Hyperglycemia |
2.69 ± 1.74 |
2.31 ± 1.49 |
0.5180 |
3. Hypoglycemia |
1.75 ± 1.34 |
2.38 ± 1.26 |
0.1842 |
4. Convenience |
4.44 ± 1.46 |
3.56 ± 0.63 |
0.0354 |
5. Flexibility |
4.44 ± 1.50 |
3.56 ± 0.81 |
0.0496 |
6. Understanding |
4.31 ± 1.74 |
3.56 ± 0.89 |
0.1355 |
7. Recommend |
4.13 ± 1.67 |
3.81 ± 1.05 |
0.5305 |
8. Continue |
4.25 ± 1.34 |
3.81 ± 0.98 |
0.3008 |
9. Overalla |
25.88 ± 8.71 |
22.13 ± 4.54 |
0.1372 |
Values
are expressed as means ± S.D. aCombined score of 1, 4, 5, 6, 7, and 8.
(B)
|
Basal insulin
group (n = 17) |
Premixed
insulin group (n = 16 |
P value |
1. Current treatment |
1.59 ± 1.37 |
1.19 ± 1.11 |
0.3650 |
2. Hyperglycemia |
-0.71 ± 1.45 |
-1.06 ± 1.06 |
0.4284 |
3. Hypoglycemia |
-0.88 ± 1.41 |
-0.50 ± 1.10 |
0.3929 |
4. Convenience |
2.00 ± 1.00 |
0.81 ± 0.91 |
0.0012 |
5. Flexibility |
1.71 ± 1.26 |
0.60 ± 0.74 |
0.0058 |
6. Understanding |
1.53 ± 1.28 |
0.75 ± 0.93 |
0.0556 |
7. Recommend |
1.76 ± 1.30 |
0.56 ± 0.81 |
0.0035 |
8. Continue |
1.94 ± 1.25 |
0.69 ± 0.95 |
0.0029 |
9. Overalla |
10.53 ± 6.73 |
4.13 ± 4.64 |
0.0043 |
Values
are expressed as means ± S.D. aCombined score of 1, 4, 5, 6, 7, and 8.